FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Capecitabine Tablet
Status: Resolved
»Duration of Shortage: 02/09/2023 - 05/21/2024
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Revised 06/27/2024)

Company Contact Information:
866-941-7875, option 2

Presentation

• Tablet, 500 mg (NDC 16729-073-29)

Note:

• Available

Dr. Reddy's Laboratories, Inc. (Revised 06/27/2024)

Company Contact Information:
866-732-3952

Presentation

• Tablet, 150 mg (NDC 55111-496-60)
• Tablet, 500 mg (NDC 55111-497-04)

Note:

• Available

Eugia US LLC (Revised 05/21/2024)

Company Contact Information:
888-238-7880

Presentation

• Tablet, 150 mg (NDC 59651-204-60)
• Tablet, 500 mg (NDC 59651-205-08)

Note:

• N/A

Novadoz Pharmaceuticals LLC (Revised 05/21/2024)

Company Contact Information:
848-200-1906

Presentation

• Capecitabine, Tablet, 500 mg (NDC 72205-007-92)
• Capecitabine, Tablet, 150 mg (NDC 72205-006-60)

Note:

• Manufactured by MSN Laboratories Private Limited (Formulation Division)

Teva Pharmaceuticals USA, Inc. (Revised 05/21/2024)

Company Contact Information:
800-545-8800

Presentation

• Capecitabine Tablets USP, Tablet, 150 mg (NDC 0093-7473-06)
• Capecitabine Tablets USP, Tablet, 500 mg (NDC 0093-7474-89)

Note:

• N/A